Contact Us
  • Choose License Type

High Potency Active Pharmaceutical Ingredients (HPAPIs) can be broadly categorized as branded or generic on the basis of their customer base. Demand for high potency active pharmaceutical ingredients (HPAPIs) is rapidly increasing due to their s ability to target diseased cells more precisely and selectively than other APIs.

Statistics:

The global high potency active pharmaceutical ingredients market is expected to reach US$ 40,983.82 Mn by the end of 2027.

Global High Potency Active Pharmaceutical Ingredients Market: Drivers

Increasing launch of antibody drug conjugates is expected to propel growth of the global high potency active pharmaceutical ingredients market over the forecast period. For instance, in January 2020, Proteintech Group, an antibody manufacturer, launched over 500 antibodies directly conjugated with high-performance CoraLite488 and CoraLite594 dyes.

Global High Potency Active Pharmaceutical Ingredients Market: Opportunities

Significant growth in the pharmaceutical sector is expected to offer lucrative growth opportunities for players in the global high potency active pharmaceutical ingredients market. For instance, according to The European Federation of Pharmaceutical Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe invested US$ 19, 509 million in 2000, which increased to US$ 39,895 million (est.) in 2018. 

Global High Potency Active Pharmaceutical Ingredients Market: Restraints

Stringent regulations regarding manufacturing is expected to hinder growth of the global high potency active pharmaceutical ingredients market.

Key Takeaways:

The global high potency active pharmaceutical ingredients market was valued at US$ 19,258.8 Mn in 2019 and is forecast to reach a value of US$ 40,983.82 Mn by 2027 at a CAGR of 9.9% between 2020 and 2027. Major factor driving the growth of global high potency active pharmaceutical ingredients market during the forecast period include technological advancement, and increasing product launches.

Innovative molecules segment held dominant position in the global high potency active pharmaceutical ingredients market in 2019, accounting for 70.3% share in terms of value, followed by generic molecules, respectively. Robust pipeline of innovative molecules is expected to support growth of the segment over the forecast period.

Market Trends

Major players in the market are focused on expanding their production capacity to enhance their market share. For instance, in August 2020, SEQENS inaugurated an innovative HPAPI unit for the production of highly active ingredients at its Villeneuve-La-Garenne site, France.

Major players in the global high potency active pharmaceutical ingredients market are also focused on launching new products to expand their product portfolio. For instance, in June 2020, Ajinomoto Bio-Pharma Services launched AJILITY, a flexible and agile drug product manufacturing platform, designed to advance vaccines and therapies to market by minimizing time to production.

Global High Potency Active Pharmaceutical Ingredients Market: Competitive Landscape   

Major players operating in the global high potency active pharmaceutical ingredients market include, Lonza, Novartis International AG, BASF AG, SEQENS, Carbogen Amcis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd Bristol-Myers Squibb, Pfizer Inc., Roche Diagnostics, Boehringer Ingelheim, Covidien Plc, Merck & Co, Bayer AG, MilliporeSigma, SEQENS, Ajinomoto Bio-Pharma Services, Cambrex Corporation, Minakem, and Sanofi Aventis.

Global High Potency Active Pharmaceutical Ingredients Market: Key Developments

Major players in the global high potency active pharmaceutical ingredients market are focused on adopting M&A strategies to enhance their market share. For instance, in June 2020, Ajinomoto Bio-Pharma Services acquired Granules OmniChem Private Limited.

Major players in the market are also focused on expanding their production capacity to enhance their market share. For instance, in June 2018, Minakem, the CDMO division of Minafin started a new closed-controlled environment high containment production facility for production of high potency active pharmaceutical ingredients.

To know the latest trends and insights prevalent in the Global High Potency Active Pharmaceutical Ingredients Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/high-potency-active-pharmaceutical-ingredients-market-1336

Segmentation

  • By Molecule Type
    • Innovative
    • Generic
  • By Production Technology
    • Chemical Synthesis
    • Biotechnology
  • By Application
    • Oncology
    • Hormonal
    • Glaucoma
    • Others
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner